These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9572232)

  • 41. Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study.
    Crosignani PG; De Cecco L; Gastaldi A; Venturini PL; Oldani S; Vegetti W; Sémino A; La Commare P; Vercellini P
    Hum Reprod; 1996 Dec; 11(12):2732-5. PubMed ID: 9021380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):593-5. PubMed ID: 2137979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
    Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up.
    Pierce SJ; Gazvani MR; Farquharson RG
    Fertil Steril; 2000 Nov; 74(5):964-8. PubMed ID: 11056241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.
    Wemme H; Pohlenz J; Schönberger W
    Eur J Pediatr; 1995 Oct; 154(10):807-10. PubMed ID: 8529677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol].
    Palagiano A; Capuano V
    Minerva Ginecol; 1994 Apr; 46(4):173-7. PubMed ID: 8065590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroidal 'add-back' therapy in patients treated with GnRH agonists.
    Freundl G; Gödtke K; Gnoth C; Godehardt E; Kienle E
    Gynecol Obstet Invest; 1998; 45 Suppl 1():22-30; discussion 35. PubMed ID: 9628521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A meta-analysis of preventing bone mineral loss in patients with endometriosis treated by gonadotrophin-releasing hormone analogues with add-back therapy].
    Niu ZR; Yue XJ; Kong QY; Wang YF; Yao YQ
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):338-43. PubMed ID: 24016475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of progestins.
    Mishell DR
    Postgrad Med; 1989 Apr; Spec No():84-8; discussion 89-90. PubMed ID: 2542913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.
    Casper RF
    Fertil Steril; 2017 Mar; 107(3):533-536. PubMed ID: 28162779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group.
    Dlugi AM; Miller JD; Knittle J
    Fertil Steril; 1990 Sep; 54(3):419-27. PubMed ID: 2118858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The efficacy and safety of domestic luteinizing hormone-releasing hormone analogue and low-dose norethindrone "add-back" therapy in the treatment of endometriosis].
    Zhang S; Ye G; Chen H
    Zhonghua Fu Chan Ke Za Zhi; 2000 Aug; 35(8):482-5. PubMed ID: 11776204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report.
    Surrey ES; Fournet N; Voigt B; Judd HL
    Obstet Gynecol; 1993 Apr; 81(4):581-6. PubMed ID: 8459971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leuprorelin implant (ALZA). DUROS, leuprolide acetate implant, leuprolide implant, Viadur.
    Drugs R D; 1999 Dec; 2(6):425-6. PubMed ID: 10763458
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enatone-Gyn monthly depot): a multicenter study].
    Schindler AE; Bühler K; Gerhard I; Wiedemann R; Kimmig R; Schüssler B; Kranzfelder D; Mall-Häfeli M; Meinen K; Mancarella D
    Zentralbl Gynakol; 1994; 116(12):679-86. PubMed ID: 7846980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis.
    Matalliotakis IM; Arici A; Goumenou AG; Katassos T; Karkavitsas N; Koumantakis EE
    Int J Fertil Womens Med; 2004; 49(2):75-8. PubMed ID: 15188832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose effects of progesterone in add-back therapy during GnRHa treatment.
    Cheung TH; Lo KW; Yim SF; Lam C; Lau E; Haines C
    J Reprod Med; 2005 Jan; 50(1):35-40. PubMed ID: 15730171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
    Agrawal R; Prelevic G; Conway GS; Payne NN; Ginsburg J; Jacobs HS
    Fertil Steril; 2000 Jan; 73(1):56-60. PubMed ID: 10632412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of subsequent surgery rates among endometriosis patients who underwent surgery with and without concomitant leuprolide acetate therapy.
    Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
    Curr Med Res Opin; 2016 Jun; 32(6):1073-82. PubMed ID: 27027333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.